牵连 发表于 2025-3-25 03:55:06

http://reply.papertrans.cn/1/84/8345/8345-21.png

Dawdle 发表于 2025-3-25 07:28:51

Submitted on: 05 February 2004.
Revised on: 22 April 2004.
Accepted on: 24 May 2004.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Ceramic 发表于 2025-3-25 13:22:19

Submitted on: 19 December 2005.
Revised on: 13 February 2006.
Accepted on: 03 April 2006.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

微生物 发表于 2025-3-25 16:35:51

http://reply.papertrans.cn/1/84/8345/8345-24.png

来就得意 发表于 2025-3-25 20:59:06

http://reply.papertrans.cn/1/84/8345/8345-25.png

oncologist 发表于 2025-3-26 00:19:55

http://reply.papertrans.cn/1/84/8345/8345-26.png

使成波状 发表于 2025-3-26 06:20:58

http://reply.papertrans.cn/1/84/8345/8345-27.png

形容词 发表于 2025-3-26 10:46:37

Submitted on: 29 August 2005.
Revised on: 06 October 2005.
Accepted on: 08 November 2005.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

exhibit 发表于 2025-3-26 14:05:25

Submitted on: 07 June 2012.
Revised on: 20 September 2012.
Accepted on: 16 October 2012.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

机制 发表于 2025-3-26 17:59:23

Submitted on: 04 May 2004.
Revised on: 26 June 2004.
Accepted on: 09 July 2004.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: 1 2 [3] 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (PHARM